Sign in
BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Updates from the Field
2024
Clinical Presentantion and Management of Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa
Cagri G Besirli, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2020
Retinitis Pigmentosa
Dipankar Barua, M.Sc
Retina Image Bank: Images of the Week
2014
Category: Hereditary Retinal Disease & Genetics